Transcranial Direct Current Stimulation in Psychiatry: What Psychiatrists Need to Know

• Published in: Focus (American Psychiatric Publishing) 2019-01, Vol.17 (1), p.44-49
• Main Authors: Zandvakili, Amin, Berlow, Yosef Alfred, Carpenter, Linda Leigh, Philip, Noah Stephen
• Format: Article
• Language: English
• ISSN: 1541-4094; 1541-4108
• DOI: 10.1176/appi.focus.20180029

Transcranial direct current stimulation is emerging as a potential treatment for a host of neuropsychiatric disorders, yet study results are mixed. This review covers tDCS essentials for psychiatric clinicians and trainees, including guidelines on tDCS treatment management. Transcranial direct current stimulation (tDCS) is emerging as a potential treatment for a host of neuropsychiatric disorders. Data appear to indicate that tDCS applied over frontal or prefrontal brain regions may reduce symptoms of major depression, yet results have been mixed. Early studies showed promise, but recent work failed to replicate earlier results. The decision whether to use tDCS is further affected by the complex regulatory environment; no tDCS devices are cleared by the U.S. Food and Drug Administration for clinical use. Older systems have grandfathered regulatory approval for treating mood, anxiety, and insomnia, although they have not demonstrated efficacy in rigorous trials. Furthermore, as the field of noninvasive brain stimulation advances, various side effects and contraindications are increasingly recognized. Over the last few years, research and consumer use of tDCS have outpaced education, thus providing little guidance for clinicians and trainees about how to understand tDCS. Therefore, this focused review includes those items psychiatric clinicians and trainees most need to understand tDCS, including basic electrical and neurophysiological principles, a brief review of efficacy data in major depressive disorder, and suggested guidelines about how to manage patients using tDCS.